Aquatic Capital Management LLC increased its position in shares of Cabot Co. (NYSE:CBT - Free Report) by 268.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,494 shares of the specialty chemicals company's stock after purchasing an additional 14,207 shares during the period. Aquatic Capital Management LLC's holdings in Cabot were worth $1,780,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of the company. Nebula Research & Development LLC lifted its stake in shares of Cabot by 85.0% during the 4th quarter. Nebula Research & Development LLC now owns 17,134 shares of the specialty chemicals company's stock valued at $1,565,000 after buying an additional 7,871 shares in the last quarter. Hancock Whitney Corp lifted its stake in shares of Cabot by 6.0% during the 4th quarter. Hancock Whitney Corp now owns 142,137 shares of the specialty chemicals company's stock valued at $12,979,000 after buying an additional 8,058 shares in the last quarter. Pinebridge Investments L.P. lifted its stake in shares of Cabot by 42.7% during the 4th quarter. Pinebridge Investments L.P. now owns 22,076 shares of the specialty chemicals company's stock valued at $2,016,000 after buying an additional 6,604 shares in the last quarter. Hsbc Holdings PLC lifted its stake in shares of Cabot by 359.1% during the 4th quarter. Hsbc Holdings PLC now owns 23,367 shares of the specialty chemicals company's stock valued at $2,129,000 after buying an additional 18,277 shares in the last quarter. Finally, Stifel Financial Corp lifted its stake in shares of Cabot by 68.2% during the 4th quarter. Stifel Financial Corp now owns 75,717 shares of the specialty chemicals company's stock valued at $6,914,000 after buying an additional 30,694 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company's stock.
Analysts Set New Price Targets
A number of research analysts recently weighed in on the stock. StockNews.com upgraded shares of Cabot from a "hold" rating to a "buy" rating in a research note on Thursday, April 17th. JPMorgan Chase & Co. decreased their price target on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research note on Friday, February 21st. Mizuho decreased their price target on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 7th. Finally, UBS Group decreased their price target on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research note on Monday, April 7th.
View Our Latest Analysis on Cabot
Cabot Price Performance
Cabot stock opened at $79.02 on Tuesday. Cabot Co. has a 52-week low of $73.63 and a 52-week high of $117.46. The company has a quick ratio of 1.29, a current ratio of 2.00 and a debt-to-equity ratio of 0.72. The firm's fifty day moving average is $81.74 and its 200 day moving average is $93.34. The company has a market cap of $4.28 billion, a price-to-earnings ratio of 10.49, a PEG ratio of 0.74 and a beta of 1.04.
Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Sell-side analysts forecast that Cabot Co. will post 7.57 EPS for the current fiscal year.
Cabot Company Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.